ACINETWORK

ACINETWORK is a European Training Network funded in the framework of HORIZON Marie Skłodowska-Curie Doctoral Networks (DN). ACINETWORK is a multidisciplinary network that aims to educate the next generation of young scientists capable of rationally designing innovative glycoconjugate vaccines to improve current preventive therapies and tackle unmet medical needs in the fight against nosocomial diseases. The main goal of ACINETWORK is to forge young professionals within an integrated research training programme in academia and industrial environments on the design and development of novel glycoconjugate vaccine candidates as treatment against severe and life-threatening infections caused by the multidrug-resistant bacterium Acinetobacter baumannii, a major cause of nosocomial diseases.

ACINETWORK will pursue this ambitious goal through a collaborative effort involving 7 academic groups, and 1 industrial partner as Beneficiaries, along with 8 Associated Partners. The combination of the beneficiaries’ expertise
in carbohydrate synthesis, conjugation techniques, nanotechnology, molecular glycobiology, cell biology, immunology and vaccinology, along with a wide experience in business and technological transfer, will create a multidisciplinary environment in which 10 Doctoral Candidates (DCs) can nourish their skills and the most innovative ideas in the growing fields of glycoscience and vaccinology, and simultaneously acquire transferable know-how that will enable them to become the new leaders of academic or industrial research. In parallel, ACINETWORK will improve the European competitiveness and innovation capacity by bringing to market and policy stakeholders new glycoscience concepts in the development of novel therapeutic options to tackle unmet medical needs and major global healthcare challenges. For more information on ACINETWORK visit www.acinetwork.eu.